ArticleActive
Billing and Coding: MolDX: Inivata, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
A57665
Effective: July 1, 2023
Updated: December 31, 2025
Policy Summary
This policy provides billing and coding instructions for the Inivata InVisionFirst–Lung liquid biopsy for patients with lung cancer. Claims must use CPT 81479 with 1 unit of service, include the appropriate DEX Z‑Code adjacent to the CPT code in specified Part A/Part B claim fields (Loop 2400/SV101-7 or Item 19 for Part B; Line SV202-7 or Block 80/UB04 for Part A), and list the appropriate ICD-10-CM lung cancer diagnosis code.
Coverage Criteria Preview
Key requirements from the full policy
"InVisionFirst–Lung liquid biopsy testing is for patients with a documented diagnosis of lung cancer."
Sign up to see full coverage criteria, indications, and limitations.